Ochoa syndrome
|
disease |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Congenital Abnormality
|
5
|
7
|
0.020 |
None |
1.000 |
2 |
|
1999 |
2003 |
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
25
|
35
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Homocystinuria
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases; Nervous System Diseases
|
Disease or Syndrome
|
39
|
27
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Hyperoxia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
50
|
|
0.200 |
None |
1.000 |
1 |
|
2010 |
2010 |
Aspartate aminotransferase measurement
|
phenotype |
|
Laboratory Procedure
|
57
|
76
|
0.100 |
None |
1.000 |
2 |
1
|
2013 |
2019 |
Acute Lung Injury
|
disease |
Respiratory Tract Diseases
|
Injury or Poisoning
|
93
|
3
|
0.200 |
None |
1.000 |
1 |
|
2015 |
2015 |
Myocardial Diseases, Secondary
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
101
|
|
0.200 |
None |
1.000 |
1 |
|
2011 |
2011 |
Cardiomyopathies, Primary
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
108
|
1
|
0.200 |
None |
1.000 |
1 |
|
2011 |
2011 |
Severe Acute Respiratory Syndrome
|
disease |
Infections; Respiratory Tract Diseases
|
Disease or Syndrome
|
117
|
1
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Biliary cirrhosis
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
132
|
36
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Xeroderma Pigmentosum
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Congenital Abnormality
|
137
|
35
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Enzyme inhibition disorder
|
phenotype |
|
Disease or Syndrome
|
171
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Febrile Convulsions
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
192
|
65
|
0.200 |
None |
1.000 |
1 |
|
2014 |
2014 |
Pseudohyperkalemia Cardiff
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
218
|
60
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Icterus
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
241
|
17
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Peripheral Arterial Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
319
|
128
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Periodontal Diseases
|
group |
Stomatognathic Diseases
|
Disease or Syndrome
|
326
|
22
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Adult Myelodysplastic Syndrome
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
332
|
20
|
0.020 |
None |
1.000 |
2 |
|
2006 |
2008 |
Childhood Myelodysplastic Syndrome
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
335
|
20
|
0.020 |
None |
1.000 |
2 |
|
2006 |
2008 |
Transient Ischemic Attack
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
344
|
16
|
0.200 |
None |
1.000 |
1 |
|
2010 |
2010 |
Stage 0 Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Stage IIA Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Stage IIB Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Stage III Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Stage IV Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |